Design and Development of a Behaviorally Active Recombinant Neurotrophic Factor
Nicholas J Pekas,1 Jason L Petersen,2,3 Monica Sathyanesan,1,2 Samuel S Newton1,2 1Department of Basic Biomedical Sciences, University of South Dakota Sanford School of Medicine, Vermilion, SD, USA; 2Sioux Falls VA Health Care System, Sioux Falls, SD, USA; 3Department of Internal Medicine, Universit...
Main Authors: | Pekas NJ, Petersen JL, Sathyanesan M, Newton SS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/design-and-development-of-a-behaviorally-active-recombinant-neurotroph-peer-reviewed-article-DDDT |
Similar Items
-
Erythropoietin and Non-Erythropoietic Derivatives in Cognition
by: Samuel S. Newton, et al.
Published: (2021-09-01) -
STAT5 as a Key Protein of Erythropoietin Signalization
by: Zuzana Tóthová, et al.
Published: (2021-07-01) -
Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01) -
Erythropoietin and Its Angiogenic Activity
by: Patrícia Kimáková, et al.
Published: (2017-07-01) -
Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections
by: Feihong Liang, et al.
Published: (2021-04-01)